EHC Encompass Health Corp

$97.96 +0.07%

Encompass Health Corp (EHC) is a healthcare company in the Services-Hospitals industry, with a market capitalization of $9.7 billion. Shares last traded at $97.96, 23.4% below their 52-week high. Over the past year the stock is down 17.8%. EHC trades at a price-to-earnings ratio of 17.16, below the Healthcare median of 25.98. Net profit margin is 9.5%, above the peer median of 0.0%. Revenue grew 10.5% year over year. The shares yield 1.1% in dividends.

Market Cap

$9.7B

Shares Out

99.2M

EPS (TTM)

$10.39

P/E Ratio

9.43

P/S Ratio

1.64

P/B Ratio

3.85

Dividend / Share

$1.08

Dividend Yield

1.10%

52-Week High

$127.85

52-Week Low

$92.81

Volume

71,008

Avg Vol (3m)

56,673.27

Performance

-4.29%

-6.51%

+0.03%

-9.30%

YTD

-7.89%

-17.78%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

38.72

SMA (50)

$104.10

SMA (200)

$109.59

Price vs SMA50

-5.90%

Price vs SMA200

-10.62%

ATR (14)

$2.91

Financials

Revenue

$5.9B

Net Income

$566M

Gross Margin

—

Operating Margin

9.1%

Net Margin

9.5%

Return on Equity

22.5%

Return on Assets

7.7%

Current Ratio

1.17

Debt / Equity

0.48

Revenue Growth (YoY)

+10.5%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$1.93	2026-05-01
FY 2025	$5.54	2026-02-26
Q3 2025	$4.11	2025-10-31
Q2 2025	$2.87	2025-08-06
Q1 2026	$1.48	2026-05-01
FY 2025	$4.46	2026-02-26

Full earnings history →

Healthcare peers

EHC vs 14 sector peers (Healthcare), by market cap.

P/E vs peers

17.16 / 25.98 med

-34% discount

P/S vs peers

1.64 / 2.59 med

-37% discount

Net margin vs peers

9.5% / 0.0% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
LIN	Linde	$236.9B	34.34	6.97	20.3%	-0.75%
AMGN	Amgen	$182.1B	23.62	4.96	21.0%	-1.27%
TMO	Thermo Fisher Scientific	$172.7B	25.70	3.88	15.1%	+0.67%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
GILD	Gilead Sciences	$153.5B	18.04	5.21	28.9%	-1.46%
ISRG	Intuitive Surgical	$144.0B	50.41	14.30	28.4%	+1.06%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
DHR	Danaher Corporation	$125.4B	34.70	5.10	14.7%	-0.38%
SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.